Patient Characteristics
| . | Number . |
|---|---|
| Total no. pts. | 56 |
| Age (median) | 29.5 yr (range 18 to 56) |
| Male | 26 |
| Female | 30 |
| B symptoms at relapse | |
| No | 35 |
| Yes | 21 |
| Stage at relapse | |
| I* | 6 |
| II* | 13 |
| III† | 9 |
| IV† | 28 |
| Extranodal sites at relapse | |
| 0 | 26 |
| 1 | 19 |
| 2 | 9 |
| 3 | 1 |
| 4 | 1 |
| Histology | |
| Nodular sclerosis | 48 |
| Mixed cellularity | 7 |
| Lymphocyte depletion | 1 |
| Prior treatments | |
| MOPP | 5 |
| ABVD | 6 |
| MOPP/ABV, MOPP/ABVD or CVPP/ABDIC | 45 |
| Disease status | |
| Primary refractory (<PR) | 7 |
| PR | 6 |
| First relapse | 33 |
| Second relapse | 10 |
| Response duration | |
| <12 mo | 33 |
| ≥12 mo | 23 |
| . | Number . |
|---|---|
| Total no. pts. | 56 |
| Age (median) | 29.5 yr (range 18 to 56) |
| Male | 26 |
| Female | 30 |
| B symptoms at relapse | |
| No | 35 |
| Yes | 21 |
| Stage at relapse | |
| I* | 6 |
| II* | 13 |
| III† | 9 |
| IV† | 28 |
| Extranodal sites at relapse | |
| 0 | 26 |
| 1 | 19 |
| 2 | 9 |
| 3 | 1 |
| 4 | 1 |
| Histology | |
| Nodular sclerosis | 48 |
| Mixed cellularity | 7 |
| Lymphocyte depletion | 1 |
| Prior treatments | |
| MOPP | 5 |
| ABVD | 6 |
| MOPP/ABV, MOPP/ABVD or CVPP/ABDIC | 45 |
| Disease status | |
| Primary refractory (<PR) | 7 |
| PR | 6 |
| First relapse | 33 |
| Second relapse | 10 |
| Response duration | |
| <12 mo | 33 |
| ≥12 mo | 23 |